Literature DB >> 9253368

Prolactinomas apparently resistant to quinagolide respond to cabergoline therapy.

A Colao, G Lombardi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9253368     DOI： 10.1210/jcem.82.8.4178-3

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  3 in total

1.  Prospective, long-term study of the effect of cabergoline on valvular status in patients with prolactinoma and idiopathic hyperprolactinemia.

Authors:  Laurent Vroonen; Patrizio Lancellotti; Monica Tomé Garcia; Raluca Dulgheru; Matilde Rubio-Almanza; Ibrahima Maiga; Julien Magne; Patrick Petrossians; Renata Auriemma; Adrian F Daly; Albert Beckers
Journal:  Endocrine       Date:  2016-10-05       Impact factor: 3.633

Review 2.  New medical treatment for acromegaly.

Authors:  A J van der Lely; W W de Herder; S W Lamberts
Journal:  Pituitary       Date:  1999-06       Impact factor: 4.107

Review 3.  Pharmacological therapy for acromegaly: a critical review.

Authors:  Alex F Muller; Aart Jan Van Der Lely
Journal:  Drugs       Date:  2004       Impact factor: 9.546
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.